Phase I trial of the folate binding protein-E39 targeted cancer vaccine to prevent recurrence in patients with breast cancer.
Phase of Trial: Phase I
Latest Information Update: 16 Oct 2012
At a glance
- Drugs GALE 301 (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 16 Oct 2012 The first patient was enrolled in August 2012 according to a US Army Deparment media release.
- 26 Sep 2011 New trial record